Patent intelligence · US
US 9193718
Quinazoline derivative and application thereof
Quinazoline derivative and application thereof
Patent details — US 9193718
- Jurisdiction
- US
- Status
- granted
- Grant date
- Nov 24, 2015
- Expiration
- Nov 19, 2035
- Claims
- 10
- CPC classes
- A61P, A61P35/00
Quick answer
US 9193718 (Quinazoline derivative and application thereof) is held by FUJIAN INSTITUTE OF RESEARCH ON THE STRUCTURE OF MATTER, CHINESE ACADEMY OF SCIENCES. Status: granted. Granted Nov 24, 2015. Expires Nov 19, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Grant date
- Expiration
- Claims
- 10
- CPC classes
- A61P, A61P35/00
More from FUJIAN INSTITUTE OF RESEARCH ON THE STRUCTURE OF MATTER, CHINESE ACADEMY OF SCIENCES
Related pharmaceutical patents in our USPTO index.
-
US 12279630
Treatment and prevention of seed allergies
granted -
US 12251417
Antimicrobial compounds from the genus Delftia
granted -
US 12139522
T-cells comprising two different chimeric antigen receptors and uses thereof
granted -
US 12134650
Compositions targeting GABRA2 and methods for diagnosis and treatment of cancer
granted -
US 12084350
Allotrope of carbon having increased electron delocalization
granted -
US 12023348
EGR1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions
granted -
US 11944644
T-cells comprising anti-CD38 and anti-CD138 chimeric antigen receptors and uses thereof
granted -
US 11932871
Methods of culturing t cells and uses of same
granted
Frequently asked questions
What is US patent 9193718?
US 9193718 (Quinazoline derivative and application thereof) is held by FUJIAN INSTITUTE OF RESEARCH ON THE STRUCTURE OF MATTER, CHINESE ACADEMY OF SCIENCES. Status: granted. Granted Nov 24, 2015. Expires Nov 19, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9193718?
FUJIAN INSTITUTE OF RESEARCH ON THE STRUCTURE OF MATTER, CHINESE ACADEMY OF SCIENCES is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 93 pharmaceutical patents for this assignee.
When does US 9193718 expire?
Our index shows an expiration date of Nov 19, 2035 (9 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.